TRIPS AND IPRS: NEWS AND REPORTS ON THE NEGOTIATIONS

• WTO: DG to issue three best endeavour "Plan B" MC12 agriculture outcomes / TRIPS waiver informal drafting meeting
  by D. Ravi Kanth (31 May 22)
• WTO: TRIPS Council "outcome text" contradicts bracketed working document
  by TWN (30 May 22)
• WTO DG, TRIPS Chair "manage" TRIPS Covid-19 negotiation process
  by D. Ravi Kanth (18 May 22)
• China offers "positive movement" on TRIPS COVID-19 text at WTO
  by D. Ravi Kanth (12 May 22)
• WTO DG's "TRIPS COVID-19" text goes into uncharted waters
  by D. Ravi Kanth (10 May 22)
• WTO Secretariat misleads on status & content of intellectual property text, perpetuates confusion
  by TWN (04 May 22)
• WTO DG’s proposed solution unsuitable for global public health crisis
  by Sangeeta Shashikant (02 May 22)
• US Patent System in "dire need of reform" - NYT Editorial Board calls for action
  (18 Apr 22)
• Leaked IP text presented as "take it or leave it" by WTO Secretariat
  by TWN (29 Mar 22)
• Proposed TRIPS waiver outcome not yet agreed among the Quad
  by TWN (17 Mar 22)
• In-depth: How a Cape Town company made an mRNA vaccine and what happens next
  by Catherine Tomlinson (14 Mar 22)
• Moderna's Global Public Health Strategy: Parsing the Hype and Shameful Access Gaps
  (14 Mar 22)
• Event - TRIPS Waiver & State of Play (11th March)
  (09 Mar 22)
• WTO: Dangers of "take-it-or-leave-it" compromise outcome on TRIPS waiver
  by D. Ravi Kanth (24 Feb 22)
• North blocks India's request for virtual ministerial on TRIPS waiver
  by D. Ravi Kanth (14 Jan 22)
• WTO: GC chair to hold talks on virtual ministerial on TRIPS component
  by D. Ravi Kanth (12 Jan 22)
• US, EU, India, South Africa hold talks on TRIPS waiver compromise
  by D. Ravi Kanth (14 Dec 21)
• Developing countries call for concluding work on TRIPS waiver
  by D. Ravi Kanth (07 Dec 21)
• Pressure mounts on WTO to show its "human face" on TRIPS waiver
  by D. Ravi Kanth (02 Dec 21)
• US, EU, India, South Africa hold talks on TRIPS waiver compromise
  by D. Ravi Kanth (14 Dec 21)
• Developing countries call for concluding work on TRIPS waiver
  by D. Ravi Kanth (07 Dec 21)
• Pressure mounts on WTO to show its "human face" on TRIPS waiver
  by D. Ravi Kanth (02 Dec 21)
• EU & allies adopt "diversionary" tactics on TRIPS waiver at WTO
  by D. Ravi Kanth (11 Nov 21)
• Inviting applications for online course on "Access to Covid-19 Medical Products”
  (10 Nov 21)
• Global jurists call for waiver of global intellectual property rights for COVID-19 vaccines and therapeutics
  (09 Nov 21)
• COVID-19: UN experts call for urgent action on universal access to vaccines
  by Kanaga Raja (21 Oct 21)
• US proposes "peace clause" for disputes concerning IPRs at WTO
  by D. Ravi Kanth (21 Oct 21)
• Need to de-link TRIPS waiver from other MC12 issues
  by D. Ravi Kanth (19 Oct 21)
• Video: COVID 19 - Europe's Broken Promises on Equitable Access
  (19 Oct 21)
• South Africa's President calls for delivering on TRIPS waiver at MC12
  by D. Ravi Kanth (05 Oct 21)
• Webinar: Access Barriers to Covid-19 Therapeutics & Diagnostics: A Case for TRIPS Waiver
  (04 Oct 21)
• New publication: Pharmaceutical patents, the LDC exemption and Bangladesh
  (20 Sept 21)
• EU, Switzerland, UK continue opposition, amid support for TRIPS waiver
  by D. Ravi Kanth (16 Sept 21)
• Candidates for German Chancellor called to waive IP rules for COVID vaccines
  (15 Sept 21)
• Today High Level Dialogue -TRIPS Waiver
  (13 Sept 21)
• TRIPS waiver proposal being undermined by EU at WTO
  by D. Ravi Kanth (10 Aug 21)
• WTO-WHO Dialogue hears call to treat "patents & profits" as second priority due to COVID-19
  by D. Ravi Kanth (23 Jul 21)
• Co-sponsors remain upbeat on progressing on TRIPS waiver at WTO
  by D. Ravi Kanth (18 Jul 21)
• Progress in TRIPS waiver talks despite new hurdles created by EU
  by D. Ravi Kanth (08 Jul 21)
• Singapore & Jamaica hold meet to promote DG's "third way" approach
  by D. Ravi Kanth (07 Jul 21)
• LDCs obtain 13 year TRIPS transition period, but nothing on post-graduation
  by D. Ravi Kanth (30 Jun 21)
• New TWN Briefing paper: Trade secrets protection and vaccines: The role of medicine regulatory agencies
  by K M Gopakumar, Chetali Rao & Sangeeta Shashikant (25 Jun 21)
• Developing countries remain upbeat on TRIPS waiver negotiations
  by D. Ravi Kanth (21 Jun 21)
• WTO Members agree to text-based negotiations on revised TRIPS waiver
  by D. Ravi Kanth (11 Jun 21)
• EU proposal seeks to derail TRIPS waiver discussions at WTO
  by D. Ravi Kanth (08 Jun 21)
• Revised TRIPS waiver bolsters demand for text-based talks at WTO
  by D. Ravi Kanth (03 Jun 21)
• LDCs urged to drop "post-graduation" element under TRIPS Art. 66.1.
  by D. Ravi Kanth (21 May 21)
• Co-sponsors of TRIPS waiver proposal call for solidarity at WTO
  by D. Ravi Kanth (19 May 21)
• WTO: Will US & EU bully poorest nations on intellectual property amidst a global pandemic?
  by Sangeeta Shashikant (12 May 21)
• Door opens for TRIPS waiver textual negotiations
  by D. Ravi Kanth (12 May 21)
• Brazil: Court rules against patent extension provision
  by Lean Ka-Min (11 May 21)
• WTO members welcome US decision on TRIPS waiver
  by D. Ravi Kanth (10 May 21)
• In "monumental" decision, US expresses support for TRIPS waiver
  by D. Ravi Kanth (07 May 21)
• USTR plans to visit Geneva to discuss TRIPS waiver
  by D. Ravi Kanth (04 May 21)
• High Level Dialogue TRIPS Waiver (4 May, 3.30pm CEST)
  (01 May 21)
• Big Pharma to block TRIPS waiver at WTO, citing China & Russia
  by D. Ravi Kanth (27 Apr 21)
• TRIPS waiver proposal being held hostage on "ideological" grounds
  by D. Ravi Kanth (24 Apr 21)
• Vaccine equity event enabled "frank" discussions, claims WTO DG
  by D. Ravi Kanth (21 Apr 21)
• WTO DG's vaccine event marked by sharply differing perspectives
  by D. Ravi Kanth (17 Apr 21)
• CSOs challenge DG’s “third way”, as USTR discusses TRIPS waiver
  by D. Ravi Kanth (16 Apr 21)
• WTO-TRIPS waiver: "Third Way" Set to Reinforce Status Quo?
  by D. Ravi Kanth (12 Apr 21)
• UPDATED: Attempts to slow down discussions on TRIPS waiver at WTO
  by D. Ravi Kanth (10 Apr 21)
• Over 250 CSOs & researchers join call in support of TRIPS waiver
  by D. Ravi Kanth (24 Mar 21)
• International Research Organizations Support WTO TRIPS Waiver for COVID-19
  (22 Mar 21)
• WHO DG criticizes countries "putting lives at risk" in Covid-19 fight
  by D. Ravi Kanth (16 Mar 21)
• Strong support for TRIPS waiver amidst opposition by Big Pharma
  by D. Ravi Kanth (12 Mar 21)
• Seven countries urge WTO DG to hold direct talks with Big Pharma
  by D. Ravi Kanth (11 Mar 21)
• WTO DG's "third way" to fight COVID-19 a tough sell
  by Biswajit Dhar & K M Gopakumar (10 Mar 21)
• WTO DG meets Big Pharma and opts for voluntary licenses
  by D. Ravi Kanth (10 Mar 21)
• COVID-19: WHO DG calls for triggering of TRIPS waiver at WTO
  by D. Ravi Kanth (09 Mar 21)
• South countries demand text-based negotiations on TRIPS waiver
  by D. Ravi Kanth (03 Mar 21)
• Two-thirds of WTO members issue call for a TRIPS waiver
  by D. Ravi Kanth (25 Feb 21)
• COVID-19: Addressing pandemic-induced global medical supply issues
  by Lim Chee Han (25 Feb 21)
• US lawmakers urge Biden to support TRIPS waiver proposal at WTO
  by D. Ravi Kanth (22 Feb 21)
• Developing countries call for text-based negotiations on TRIPS waiver
  by D. Ravi Kanth (08 Feb 21)
• Several Ministers bring TRIPS waiver to center stage at ministerial meet
  by D. Ravi Kanth (02 Feb 21)
• "Global approach" based on TRIPS waiver needed to combat Covid-19
  by D. Ravi Kanth (29 Jan 21)
• COVID-19: Vaccines war underscores need for TRIPS waiver at WTO
  by D. Ravi Kanth (29 Jan 21)
• Proponents of TRIPS waiver call for text-based negotiations
  by D. Ravi Kanth (25 Jan 21)
• COVID-19: Global "moral failure" in distribution of vaccines, says WHO DG
  by D. Ravi Kanth (20 Jan 21)
• Proponents of TRIPS waiver issue documents to facilitate discussions
  by D. Ravi Kanth (19 Jan 21)
• Opponents of TRIPS waiver asked to respond to questions by proponents
  by D. Ravi Kanth (15 Jan 21)
• A Compilation of Selected Literature on the Impact of the UPOV Convention, Alternative sui generis PVP Laws and the Effect on Farmers’ Rights
  (06 Jan 21)
• COVID-19: "Big Pharma is Fooling Us"
  by Stephen Buranyi (18 Dec 20)
• COVID-19: A vaccine that was hijacked by the rich
  by IPS/Thalif Deen (14 Dec 20)
• TRIPS waiver gains more support despite efforts to stall its passage
  by D. Ravi Kanth (14 Dec 20)
• Want Vaccines Fast? Suspend Intellectual Property Rights
  by Achal Prabhala, Arjun Jayadev & Dean Baker (10 Dec 20)
• New TWN Briefing Paper on TRIPS Waiver Proposal
  by Biswajit Dhar & K.M. Gopakumar (09 Dec 20)
• US & allies adopt "diversionary" tactics to block TRIPS waiver
  by D. Ravi Kanth (08 Dec 20)
• Public services international supports waiver
  by Kanaga Raja (06 Dec 20)
• COVID-19: Compilation of TRIPS Waiver Proposal materials
  (02 Dec 20)
• WTO members should ensure access to affordable medicines
  (01 Dec 20)
• Almost 100 UK parliamentarians urge UK government to support TRIPS waiver
  (30 Nov 20)
• Amnesty International Calls on WTO Members to Strongly Support TRIPS Waiver Proposal
  (26 Nov 20)
• Developed countries continue to block TRIPS waiver proposal
  by D. Ravi Kanth (24 Nov 20)
• Waiving Intellectual Property Rules Key to Beating Covid-19
  by Aruna Kashyap & Margaret Wurth (18 Nov 20)
• The Covid vaccine will benefit humanity – we should all own the patent
  by Owen Jones (17 Nov 20)
• TRIPS Council to resume discussions next week on TRIPS waiver
  by D. Ravi Kanth (16 Nov 20)
• COVID-19: Licensing deals on vaccines reinforce need for TRIPS waiver
  by D. Ravi Kanth (12 Nov 20)
• Rights: UN experts criticize countries for hoarding COVID-19 vaccines
  by Kanaga Raja (11 Nov 20)
• UN HR Experts Welcomes Waiver
  (10 Nov 20)
• Battle-lines being drawn over upcoming discussion on TRIPS waiver
  by D. Ravi Kanth (07 Nov 20)
• LDCs call for extension of transition period to implement TRIPS
  by D. Ravi Kanth (22 Oct 20)
• South Africa, India strongly rebut arguments against TRIPS waiver
  by D. Ravi Kanth (20 Oct 20)
• Proposal for TRIPS waiver secures strong support from South
  by D. Ravi Kanth (20 Oct 20)
• Safeguarding the World's Response to COVID-19 from the Intellectual Property Police
  by Biswajit Dhar & K.M. Gopakumar (19 Oct 20)
• CSOs call for strong support for TRIPS waiver to combat COVID-19
  by Kanaga Raja (16 Oct 20)
• PHM Call to Action on TRIPS Waiver Proposal
  (15 Oct 20)
• COVID-19: CSO letter supporting TRIPS Waiver Proposal
  (15 Oct 20)
• Attempts to undermine talks on TRIPS waiver to combat COVID-19?
  by D. Ravi Kanth (14 Oct 20)
• Intellectual Property & Covid 19
  (12 Oct 20)
• India, South Africa seek TRIPS waiver to combat COVID-19
  by D. Ravi Kanth (06 Oct 20)
• COVID-19: South Africa, India call for enabling technology transfer in TRIPS
  by D. Ravi Kanth (11 Aug 20)
• South voices concerns over "vaccine nationalism" amid COVID-19
  by D. Ravi Kanth (10 Aug 20)
• COVID-19: South Africa calls for "holistic" approach to TRIPS flexibilities
  by D. Ravi Kanth (04 Aug 20)
• COVID-19: South concerned over TRIPS barrier to access affordable vaccines
  by D. Ravi Kanth (26 Jun 20)
• CSO concerns on India's IP laws, access to medical devices and US-India FTA
  (10 Feb 20)
• "Friends of the system" seek extension on e-com & TRIPS moratorium
  by D. Ravi Kanth (23 Oct 19)
• R&D costs and pricing of medicines & health technologies
  by Kanaga Raja (14 Oct 19)
• CSO Letter to RCEP Negotiators on Intellectual Property
  (25 Sept 19)
• New APBREBES Publication: A Dysfunctional Plant Variety Protection System: Ten Years of UPOV Implementation in Francophone Africa
  by Mohamed Coulibaly, Robert Ali Brac de la Perrière, with contributions from Sangeeta Shashikant (29 Apr 19)
• Investment Protection Proposals Under RCEP Threaten India's Pharma Industry
  by Prathibha Sivasubramanian (18 Mar 19)
• WHO backs South Africa's TRIPS proposal on public health
  by D. Ravi Kanth (12 Feb 19)
• South Africa challenges North on curbing anti-competitive behaviour
  by D. Ravi Kanth (09 Nov 18)
• China-South Africa for strengthened TRIPS flexibilities
  by D. Ravi Kanth (30 May 18)
• Developing nations, LDCs demand TRIPS flexibilities implementation
  by D. Ravi Kanth (21 Feb 18)
• India+4 link moratoriums on e-commerce, TRIPS NV and CBD
  by D. Ravi Kanth (14 Dec 17)
• Sharing national experiences in use of compulsory licenses
  by Kanaga Raja (03 Nov 17)
• RCEP trade agreement and access to medicines
  (04 Aug 17)
• WTO TRIPS Council debates IP and the public interest
  by Kanaga Raja (28 Jun 17)
• Mitigating the Regulatory Constraints Imposed by IP Rules under FTAs
  (06 Mar 17)
• Avoid patent clauses in trade treaties that can kill millions
  by IPS/Martin Khor (02 Mar 17)
• Major ICs seek tightening IPR framework at WTO
  by D. Ravi Kanth (16 Feb 17)
• Global day of action against Roche's inhumanity
  (07 Feb 17)
• TRIPS amendment on access to cheaper drugs comes into force
  by Kanaga Raja (25 Jan 17)
• Strong support for UN panel's recommendations on access to drugs
  by Kanaga Raja (14 Nov 16)
• The unfulfilled promises of innovation and expansion of IPRs
  by Kanaga Raja (05 Sept 16)
• EU sharply criticised over new trademarks directive
  by Kanaga Raja (17 Jun 16)
• The curious case of generic Hep C drug sofosbuvir
  by Leena Menghaney (14 Jun 16)
• CSO letter to countries negotiating RCEP
  (10 Jun 16)
• Civil Society Joint Statement on the Occasion of Prime Minister Narendra Modi’s Visit to US
  (07 Jun 16)
• Nothing Special (301) to report
  by K. M. Gopakumar (18 Apr 16)
• WHO proposes to join Global Fund's IP enforcement initiative
  by K M Gopakumar (19 Nov 15)
• TRIPS Council Decision On Extension of the Transition Period Concerning Pharmaceutical Products
  (06 Nov 15)
• Unconditional 17-year exemption from pharmaceuticals patents agreed
  by Sangeeta Shashikant (03 Nov 15)
• South moots making non-violation complaints inapplicable to TRIPS
  by D. Ravi Kanth (23 Oct 15)
• EU commitment on access to drugs is an "empty gesture"
  by Kanaga Raja (23 Oct 15)
• "Unconscionable and indefensible" - U.S. 10-year offer to LDCs for pharmaceutical patent waiver
  (21 Oct 15)
• Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines
  (25 Sept 15)
• Preliminary analysis of biologics exclusivity in the leaked Trans Pacific Partnership Agreement text
  (21 Aug 15)
• US, Big Pharma pushing to end NV dispute moratorium on TRIPS
  by Kanaga Raja (22 Jun 15)
• Strong support for LDC pharmaceuticals exemption request
  by Kanaga Raja (17 Jun 15)
• CSOs urge support for LDC request on pharmaceuticals exemption
  by Kanaga Raja (29 May 15)
• LDC request for extension of transition period on pharmaceuticals
  by K. M. Gopakumar (27 Feb 15)
• US industry patent lobby meeting with judges foiled
  by Dilasha Seth & Soma Das (24 Nov 14)
• African Regional IP Office & implications for Access to Medicines
  by Sangeeta Shashikant (20 Nov 14)
• TRIPS Council takes up plain packaging, non-violation cases issues
  by Kanaga Raja (03 Nov 14)
• Updates on Plant Variety Protection #9
  (09 Oct 14)
• CSOs concerned over timing of IP policy review in India
  by Kanaga Raja (26 Sept 14)
• No engagement yet on GI register for wines and spirits
  by Kanaga Raja (23 Apr 14)
• US leads the world in use of compulsory licenses, says KEI
  by Kanaga Raja (18 Mar 14)
• South encouraged to use TRIPS flexibilities for public health
  by Kanaga Raja (18 Mar 14)
• How Intellectual Property Reinforces Inequality by Josephe E. Stiglitz (16 Jul 13)
• SouthViews: BITs - Threat to Health by Carlos M. Correa (28 Jun 13)
• NGOs Condemn EU Press Release on TRIPS Extension for LDCs (25 Jun 13)
• South Centre Welcomes WTO Decision on LDCs and TRIPs (19 Jun 13)
• LDC TRIPS exemption approved with mixed reactions by Sangeeta Shashikant (15 Jun 13)
• WTO Approves an 8-year Extension of Transition Period for LDCs (12 Jun 13)
• Please Stop Bullying the World's Poorest Countries by Matthew Kavanagh (07 Jun 13)
• Tripping Up: LDCs, TRIPS and justice by Dr Arjun Karki (05 Jun 13)
• TRIPS hang over LDC like a sword of Damocles by Jaya Ramachandran (29 May 13)
• Bad faith negotiation tactics in LDC extension request by Brook K. Baker (28 May 13)
• Poorest nations held hostage by US/EU Demands on TRIPS compliance by Chee Yoke Ling (28 May 13)
• US and EU demand TRIPS plus concession from poorest countries by Sangeeta Shashikant (30 Apr 13)
• South supports LDCs' transition period, North creates obstacles by Simran Gathani (11 Mar 13)
• Putting the aid in AIDS by Martin Khor (25 Feb 13)
• LDCs seek indefinite extension of transition period under TRIPS by Kanaga Raja (19 Dec 12)
• FTA may cause drug prices to sky-rocket (28 Aug 12)
• Agriculture, TRIPS chairs to consult on way forward by Kanaga Raja (03 Apr 12)
• TRIPS Council discusses ACTA, Australia's packaging bill by Kanaga Raja (02 Apr 12)
• India has just granted a CL to a generic company (13 Mar 12)
• Novartis, Big Pharma, and their US and EU Surrogates Throw a Triple Punch at Indian Generics by Brook K. Baker (11 Feb 12)
• LDC TRIPS extension and non-violation for MC8 by Kanaga Raja (25 Nov 11)
• LDCs table proposal on TRIPS for MC8 by Kanaga Raja (21 Nov 11)
• Review of "Para 6" system, ACTA feature at TRIPS Council by Kanaga Raja (08 Nov 11)
• No data exclusivity clauses in trade pacts, assures India by Kanaga Raja (14 Jul 11)
• Developing countries propose TRIPS amendment to fight biopiracy by Chee Yoke Ling (06 Jun 11)
• WTO DG reports divergent views on GI extension, TRIPS/CBD by Kanaga Raja (18 May 11)
• TRIPS, NAMA negotiating groups still divided on key issues by Kanaga Raja (29 Apr 11)
• A complete draft text emerges on GI register for wines and spirits by Kanaga Raja (10 Mar 11)
• Bolivia submits detailed paper on TRIPS Article 27.3(b) by Kanaga Raja (09 Mar 11)
• Positions unchanged on biodiversity issues, "Para 6" system by Kanaga Raja (09 Mar 11)
• Draft text on GI register for wines and spirits takes shape by Kanaga Raja (23 Feb 11)
• Work continues on draft text on GI register for wines and spirits by Kanaga Raja (08 Feb 11)
• Work begins on draft text on GI register for wines and spirits by Kanaga Raja (21 Jan 11)
• Leading law academics call for halt to ACTA by Kanaga Raja (09 Nov 10)
• Concerns raised over ACTA at TRIPS Council by Kanaga Raja (09 Nov 10)
• TRIPS Council holds in-depth review of "Para 6" system by Kanaga Raja (09 Nov 10)
• ACTA comes in for criticism at TRIPS Council by Kanaga Raja (21 Jun 10)
• TRIPS Council discusses Art. 27.3 (b) review, "Para 6" system by Kanaga Raja (21 Jun 10)
• India, Brazil raise dispute over EU drug seizures by Kanaga Raja (21 May 10)
• NGOs concerned over WHO's role in "counterfeit" drugs, IMPACT by Kanaga Raja (17 May 10)
• Praise for Ecuador's grant of compulsory license for AIDS drug by Kanaga Raja (04 May 10)
• US access-to-drugs policy contravenes human rights, say groups by Kanaga Raja (04 May 10)
• Concerns over EU-India FTA's impact on drugs access by Kanaga Raja (22 Mar 10)
• Brazil begins process to retaliate on US non-compliance by Kanaga Raja (20 Mar 10)
• Positions remain unchanged on GI register by Kanaga Raja (12 Mar 10)
• Bolivia calls for in-depth review of TRIPS Article 27.3(b) by Kanaga Raja (09 Mar 10)
• TRIPS Council addresses patents on life forms and access to medicines by Kanaga Raja (09 Mar 10)
• Members discuss implementation of TRIPS "Para 6" solution by Kanaga Raja (22 Feb 10)
• Talks on GI register should focus on "practical" issues by Kanaga Raja (17 Feb 10)
• WHO: Virus-Benefit Sharing Working Group set up, pandemic flu response to be reviewed by Sangeeta Shashikant (27 Jan 10)
• WHO: Expert report on R&D financing triggers inquiry, consultations by Sangeeta Shashikant (22 Jan 10)
• Patents on Tanzania’s sorghum raise legal, ethical questions by Riaz K. Tayob (21 Jan 10)
• International negotiations to prevent bio-piracy resume by Chee Yoke Ling (13 Nov 09)
• Pillaging of African biological resources continues, study finds by Riaz K. Tayob (11 Nov 09)
• TRIPS Council takes up public health, TRIPS/CBD, drug seizure issues by Kanaga Raja (04 Nov 09)
• South signals direction on patents, Development Agenda, enforcement by Sangeeta Shashikant (07 Oct 09)
• WIPO: Members renew IGC's mandate calling for text-based negotiations by Sangeeta Shashikant (06 Oct 09)
• Attempts to revive talks on broadcasting, audiovisual treaties by Sangeeta Shashikant (30 Sept 09)
• Developing countries voice "development concerns" over WIPO by Sangeeta Shashikant (30 Sept 09)
• WIPO chief's agenda raises development concerns by Sangeeta Shashikant (28 Sept 09)
• South-East Asian Member States reject IP enforcement agenda by K. M. Gopakumar (28 Sept 09)
• South Bulletin on IP Rights & Wrongs (23 Sept 09)
• The ‘Enola Bean’ dispute: patent failure & lessons for developing countries by Sangeeta Shashikant & Asmeret Asghedom (12 Aug 09)
• Lamy reports on GI extension, TRIPS/CBD consultations by Kanaga Raja (05 Aug 09)
• Pope denounces North's zeal for rigidly asserting IPRs by Kanaga Raja (20 Jul 09)
• EU demands in EU-India FTA could adversely affect access to drugs by Sangeeta Shashikant (29 Jun 09)
• Concerns voiced at TRIPS Council over seizure of drugs by Sangeeta Shashikant (16 Jun 09)
• TRIPS and FTAs have adverse impact on access to drugs by Kanaga Raja (15 Jun 09)
• TRIPS Chair urges "more substantive" talks on GI register by Kanaga Raja (02 Jun 09)
• NGOs voice concerns to WHO, WTO on seizure of generic drugs by Kanaga Raja (23 Feb 09)
• Panel decision on IP case favourable to China, say experts by Sanya Reid Smith (10 Feb 09)
• Developing countries attack Dutch seizure of generic medicines by Sangeeta Shashikant (06 Feb 09)
• WHO: Concerns voiced over IMPACT, Secretariat's role on "counterfeits" by Sangeeta Shashikant (02 Feb 09)
• WHO: Counterfeit taskforce may block legitimate access to generics by Sangeeta Shashikant (23 Jan 09)
• Health: WHO/Big Pharma counterfeit plans receive harsh criticism by Riaz K. Tayob (19 Jan 09)
• WHO: Approach to "counterfeit" drugs may affect access to medicines by Sangeeta Shashikant (19 Jan 09)
• WCO secretariat for disbanding SECURE Working Group by Sangeeta Shashikant (09 Dec 08)
• No change in positions on GI register/extension, TRIPS disclosure by Kanaga Raja (05 Dec 08)
• Counterfeit issue stirs debate among WHO member states by Sangeeta Shashikant & Riaz K Tayob (12 Aug 08)
• Controversy on proposed IP rules at World Customs Organisation by Sangeeta Shashikant (12 Aug 08)
• Development: UN postal agency being roped in to enforce IPR agenda by Sangeeta Shashikant & Riaz K Tayob (08 Aug 08)
• Different views as WIPO strives to implement Development Agenda by Riaz K. Tayob & K. M. Gopakumar (21 July 08)
• WIPO: Meeting adopts report on Development Agenda activities by Riaz K. Tayob & K. M. Gopakumar (21 July 08)
• WIPO: Patents committee begins work with usual North-South differences by Sangeeta Shashikant (30 June 08)
• WIPO: Meeting on patent law, as Secretariat issues report by Sangeeta Shashikant (30 June 08)
• Trade: No change in positions on TRIPS disclosure, "parallelism" by Kanaga Raja (28 June 08)
• Trade: US academic exposes IP maximalists' TRIPS-Plus-Plus agenda by Sangeeta Shashikant (24 June 08)
• Trade: WTO Director-General issues report on GI extension, TRIPS/CBD talks by Kanaga Raja (17 June 08)
• Trade: TRIPS Chair issues report on GI register talks by Kanaga Raja (17 June 08)
• Agreed roadmap to complete access/benefit sharing regime by TWN (05 June 08)
• WHO: WHA strengthens WHO's mandate on IP and Health by Sangeeta Shashikant (04 June 08)
• WHO: Secretariat's publications policy questioned at Board meeting by Sangeeta Shashikant (04 June 08)
• Trade: TRIPS Chair to prepare report on register for wines and spirits by Kanaga Raja (22 Apr 08)
• Health: Recent Thai compulsory licenses and the aftermath by Sangeeta Shashikant (01 Apr 08)
• TRIPS: Majority of WTO members now support disclosure proposal by Martin Khor (19 Mar 08)
• No shift in positions on GI extension, TRIPS/CBD by Kanaga Raja (10 Dec 07)
• WHO Working Group on IPR and innovation finishes week of work, to meet again in April 2008 by Riaz K. Tayob (16 Nov 07)
• TRIPS: LDCs join call for TRIPS disclosure requirements by Kanaga Raja (02 Nov 07)
• Rush is on for patents on avian flu viruses and vaccines by Sangeeta Shashikant (01 Nov 07)
• Thailand issues Compulsory Licence to buy Plavix Generics from India by Bangkok Post (29 Aug 07)
• WIPO Meeting agrees to 45 proposals and new Development Committee by Sangeeta Shashikant (27 June 07)
• Support grows for TRIPS disclosure proposal by Martin Khor (15 June 07)
• Brazil moves on compulsory license after failed talks with drug company by Sangeeta Shashikant (03 May 07)
• Key Congressional Democrats against TRIPS-plus in FTAs by Riaz K. Tayob (30 Mar 07)
• Indonesia to share bird-flu samples only if there is new system by Martin Khor (23 Feb 07)
• Indonesia's move on bird flu samples highlights key access issues by Martin Khor (23 Feb 07)
• TRIPS/CBD, enforcement dominate talks at TRIPS Council by Kanaga Raja (21 Feb 07)
• Health: WHO DG regrets her reported remarks on Thai compulsory licenses by Martin Khor (15 Feb 07)
• WHO Working Group on IPRs and health holds first meeting by Sangeeta Shashikant (07 Dec 06)
• Thailand uses compulsory licence for cheaper AIDS drug by Chee Yoke Ling (06 Dec 06)
• Clash in TRIPS Council on IPR enforcement issue by Martin Khor (02 Nov 06)
• Growing movement opposing granting of drug patents by Sangeeta Shashikant (04 August 06)
• Positions remain unchanged in TRIPS/CBD consultations by Kanaga Raja (16 June 06)
• Developing countries propose new TRIPS clause to avoid bio-piracy by Sangeeta Shashikant (08 June 06)
• WHA establishes working group on IPRs and health R&D by Martin Khor (01 June 06)
• South American Ministers vow to avoid TRIPS-plus measures by Martin Khor (01 June 06)
• Report on 36 cases show biopiracy growing in Africa (14 Mar 06)
• WTO approves 'permanent solution' to TRIPS and Health (09 Dec 05)
• Rushing through a "permanent solution" for TRIPS and Health (09 Dec 05)
• TRIPS transition period for LDCs extended 7.5 years with conditions (06 Dec 05)
• Impasse on talks on TRIPS and Health "permanent solution" (28 Oct 05)
• LDCs request exemption from TRIPS for another 15 years (28 Oct 05)
• Heated Discussion as TRIPS and Health Deadline is Missed (05 April 05)
• Developing Countries Propose that TRIPS should require Patent Applications on Genetic Resources/Traditional Knowledge should Prove Benefit Sharing (18 Mar 05)
• More Consultations Needed for TRIPS/Health "Permanent Solution" (16 Mar 05)
• African Group proposal for amending TRIPS in relation to access to medicines (26 Jan 05)
• Conclusions of the Asian workshop on TRIPS and Access to Medicines (06 Dec 04)
• Calls for major reform of IP system (04 Oct 04)
• Differences remain on TRIPS and Public Health (26 Mar 04)
• No agreement yet of TRIPS Chair's statement of understanding (29 Aug 03)
• TWN comment on TRIPS Chair's statement of understanding (27 Aug 03)

• Latest developments on TRIPS and Public Health (14 Aug 03)

• No decision on para 6 at TRIPS Council meet (07 June 03)
• Africa reiterates proposal to ban life patents (11 June 03)
• WHO adopts resolution on IPRs and Public Health after wrangling over text (29 May 03)
• Asia Pacific workshop urges proper national policiesand laws to maximise rights on patents and medicines (17 April 03)
• General Council suspends decision/discussion on TRIPS para 6 negotiations (10 Feb 03)